HAYWARD, CA -- (MARKET WIRE) -- August 24, 2006 -- Aradigm Corporation (NASDAQ: ARDM) today announced that it has received notification from the Nasdaq Listing Qualifications Panel that the Company has been granted its request for continued listing on The Nasdaq Capital Market. This decision follows a hearing before the panel in which the company outlined its near-term strategies for achieving and maintaining compliance noting in particular the effect on the Company’s shareholders’ equity of the Company’s non-dilutive transaction with Novo Nordisk that was announced in early July.
